RECORA- Regorafenib in patients with metastatic colorectal cancer (mCRC) after failure of standard therapy

First published 08/10/2013

Last updated 02/07/2024

EU PAS number:

EUPAS4934

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

SV1313_CSP_2013-07-22_signed

English (859.97 KB - PDF)View document

Updated protocol

16665_SV1313_CSP_3.0_2016-04-06_signed

First published: 22/02/2024

English (2.35 MB - PDF)View document

Study results

Study results

16665_EU-PAS_Abstract

English (63.82 KB - PDF)View document

Study report

Study report

SV1313_16665_RECORA_OS report_EU PAS Register

English (1.67 MB - PDF)View document

Other information